An open trial to evaluate the efficacy and tolerability of ziprasidone IM [intramuscular] and oral in patients with psychosis and acute agitation.

Trial Profile

An open trial to evaluate the efficacy and tolerability of ziprasidone IM [intramuscular] and oral in patients with psychosis and acute agitation.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jul 2011

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BIZET
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top